Bullish
Needham Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $510
Needham has reiterated its Buy rating on Alnylam Pharmaceuticals (ALNY.US) and maintained its target price of $510. This indicates a continued positiv...